What are you
looking for?

Taking innovations to industrial scale

Publication of the Annual Report 2023

Download the reports, media release and presentation, and watch the webcast in our investors download center.
Investors download center

Siegfried is a leading contract development and manufacturing organization with a global network of 12 production sites on three continents. With 150 years of pharmaceutical and chemical experience, we are taking your innovations to industrial scale.

Our offering

As a globally leading contract development and manufacturing organization, we produce pharmaceutical ingredients and finished products as an integrated supplier.

Bringing together our long-standing pharma and chemical heritage

Learn more

Latest news

See all news
Ad hoc
Media Release Feb 20, 2024
Siegfried continues to deliver profitable growth
Media Release Feb 02, 2024
Changes in Siegfried’s Senior Management Team
Media Release Dec 13, 2023
Siegfried confirmed in the Dow Jones Sustainability Index Europe for the third consecutive year
Ad hoc
Media Release Aug 17, 2023
Siegfried delivers strong sales growth and profitability in first half 2023
Media Release May 15, 2023
Changes in Siegfried’s Executive Committee
Ad hoc
Media Release May 04, 2023
Siegfried acquires majority stake in DINAMIQS to establish a best-in-class development and manufacturing organization for cell and gene therapies
Media Release Apr 25, 2023
Siegfried begins construction of a new global R&D Center for Drug Substances in Evionnaz
Media Release Apr 20, 2023
Siegfried increases distribution and ap­points new board member
Media Release Mar 09, 2023
Siegfried opens global Development Center for Drug Products in Barcelona
Ad hoc
Media Release Feb 22, 2023
On the move since 150 years: Siegfried significantly increases sales and profits in 2022
Media Release Feb 06, 2023
Siegfried appoints Christian Dowdeswell as Chief Business Officer Drug Substances
Media Release Dec 15, 2022
Siegfried confirmed in the Dow Jones Sustainability Index Europe for the second consecutive year
To top